Navigation Links
Doro Halo Retractor System

ProductsDoro Halo Retractor System
Company Pro Med Instruments, Inc.
Item Doro Halo Retractor System
Features Lightweight, double hinged design allows a direct adaptation of the retractor arms in any position. Introduction and displacement of the retractor arms within the dovetail guide is no more necessary. Build-in hand rest guaranties stability and safety. Flexibility and versatility for all surgical approaches, as complete ring, angled or half ring set up. Ergonomic design, adapted fully to the surgical field. Newly developed arms providing a continued adjustment of the retraction. Attachable directly to the side rail of the operating table. Improved support rods provide the highest possible stability. Click-in blades eliminate obstruction of the surgical field. Adaptable to the Doro Headrest System and all other conventional head frames.
Description The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required.
Info Pro Med Instruments, Inc.
Customer Service: (877) 225-4086
Web site: http://www.headrest.de/en/produkte/index.php

Related medicine products :

1. Bloomberg Nucleus Rotator and Capsule Retractor
2. Stevenson Lacrimal Sac Retractor
3. Desmarres Lid Retractor
4. DesMarres Lid Retractor
5. Delicate Desmarres Lid Retractor
6. Desmarres Infant Retractor
7. Desmarres Retractor
8. Rigid Neck Rake Retractors
9. Flexible Rake Retractor
10. Rigid Neck Rake Retractor
11. Friedman Rake Retractor
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3JAG Media Holdings Inc Amends Articles of Incorporation 58781 1JAG Media Holdings Inc Amends Articles of Incorporation 58781 2Vermillion Announces Return of Eric Fung M D Ph D 14338 1Vermillion Announces Return of Eric Fung M D Ph D 14338 2Vermillion Announces Return of Eric Fung M D Ph D 14338 3Hamon Tower Features Critical Care Advances Potential for Reduced Costs 5195 1Hamon Tower Features Critical Care Advances Potential for Reduced Costs 5195 2